Half-year report · HY
4893.TEDINET S100YWIQ
Period2026-01-01 → 2026-06-30
Filed2026-08-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 43
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5m | 2025-01-01 → 2025-12-31 | Standalone | Operating revenues (key data) |
| Revenue | ¥4m | 2025-01-01 → 2025-06-30 | Standalone | Operating revenues (key data) |
| Operating income | −¥420m | 2026-01-01 → 2026-06-30 | Standalone | Operating income |
| Operating income | −¥413m | 2025-01-01 → 2025-06-30 | Standalone | Operating income |
| Ordinary income | −¥371m | 2026-01-01 → 2026-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥791m | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥410m | 2025-01-01 → 2025-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥371m | 2026-01-01 → 2026-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥410m | 2025-01-01 → 2025-06-30 | Standalone | Income before income taxes |
| Net income | −¥372m | 2026-01-01 → 2026-06-30 | Standalone | Profit loss |
| Net income | −¥794m | 2025-01-01 → 2025-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥412m | 2025-01-01 → 2025-06-30 | Standalone | Profit loss |
| Total assets | ¥3.7bn | at 2026-06-30 | Standalone | Assets |
| Total assets | ¥4.0bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥4.4bn | at 2025-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥90m | at 2026-06-30 | Standalone | Liabilities |
| Total liabilities | ¥80m | at 2025-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.6bn | at 2026-06-30 | Standalone | Net assets |
| Net assets / equity | ¥3.9bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥4.3bn | at 2025-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2026-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.9bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.5bn | at 2026-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.9bn | at 2025-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2025-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.7bn | at 2024-12-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥373m | 2026-01-01 → 2026-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥752m | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥357m | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | ¥132,000 | 2026-01-01 → 2026-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥378,000 | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥0 | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | −¥20,000 | 2025-01-01 → 2025-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥20,000 | 2025-01-01 → 2025-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-8.59 | 2026-01-01 → 2026-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.33 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-9.51 | 2025-01-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 97.3% | at 2026-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.8% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 98.3% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 43,399,118 | at 2026-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 43,301,765 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 43,301,765 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 349
| Item | Context | Value | Unit |
|---|---|---|---|
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東京都渋谷区千駄ヶ谷４丁目20－１神宮北参道プレックス７階 | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)玉田 耕治 | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)山口県宇部市 | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)KOREA SECURITIES DEPOSITORY-SAMSUNG（常任代理人 シティバンク、エヌ・エイ東京支店） | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)瀬戸 恭子 | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)東京都目黒区 | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)大和日台バイオベンチャー投資事業有限責任組合 | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１丁目９－１ | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)荻原 弘子 | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)東京都中野区 | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)佐古田 幸美 | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)山口県宇部市 | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)和田 聡 | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)東京都目黒区 | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)株式会社アプリコット | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都渋谷区千駄ヶ谷４丁目20－1 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsOtherMember | Original text (Japanese)完全議決権であり、権利内容に何ら限定のない当社における標準となる株式であります。なお、単元株式数は100株であります。 | |
| Description issued shares voting rights | InterimInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)ノイルイミューン・バイオテック株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都港区芝大門二丁目12番10号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | InterimDuration | Original text (Japanese)当社は、子会社がありませんので、中間連結財務諸表を作成しておりません。 | |
| Type1 semi annual balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes regarding research and development expenses (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc type1 semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | InterimDuration_NonConsolidatedMember | Original text (Japanese)当社は、がん免疫療法創薬事業の単一セグメントであり、セグメント情報の記載を省略しております。 | |
| Notes revenue recognition semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Other information financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |